Wake PA Unit 3: (PHARM) Anti-Platelets & Anti-Coagulants

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/69

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 5:37 PM on 10/7/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

70 Terms

1
New cards

Image of all anti-platelet mechanisms

knowt flashcard image
2
New cards

What is the mechanism of action of aspirin?

irreversible blocks cyclooxygenase —> inhibits arachidonic acid —> thromboxane A2 (AA axis)

3
New cards

What is the onset and duration of aspirin?

Rapid onset (minutes)

Long duration (5 days)

4
New cards

What are the SE of aspirin (outside of bleeding)?

GI upset, angioedema (rare)

5
New cards

What are the indications for aspirin?

ACS, chronic stable angina, stroke prophylaxis, PAD

6
New cards

What is the MOA for clopidogrel and prasugrel?

Thienopyridines: P2Y12 receptor inhibition (irreversible)

*P2Y12 normally binds ADP —> platelet aggregation

7
New cards

What is the onset and duration for clopidogrel and prasugrel?

Rapid onset (hours)

Long duration (5-7 days)

8
New cards

What are the SE of clopidogrel (outside of bleeding)?

Rash, TTP

9
New cards

What are the SE and C/I of prasugrel (outside of bleeding)?

rash

avoid use in TIA/stroke, age > 75, <60 kg

10
New cards

What are the indications for clopidogrel?

ACS (med management or PCI/stent), PAD, thrombotic stroke

11
New cards

What are the indications for prasugrel

ACS: PCI/stent (patients who have had mechanical intervention) *more narrow use

12
New cards

What is the MOA for ticagrelor and cangrelor?

Non-thienopyridines

P2Y12 inhibition (reversible)

*cangrelor is IV ticagrelor used in hospital setting

13
New cards

What is the onset and duration for ticagrelor and cangrelor?

ticagrelor: rapid onset (hours) and long duration (3-5 days)

cangrelor: rapid (minutes) and short duration (< 1 hour)

14
New cards

What are the SE of ticagrelor?

Dyspnea, increased serum creatinine (reversible), hyperuricemia (caution in gout)

15
New cards

What are the SE of cangrelor?

dyspnea

16
New cards

What are the indications of ticagrelor?

ACS (med management or PCI/stent)

17
New cards

What are the indications of cangrelor?

Adjunct to PCI not treated with P2Y2 inhibitor or GP2b3a inhibitor

18
New cards

What is the MOA for dipyridamole?

Inhibits platelet adensoine deaminases and phosphodiesterases ( increases cAMP which decreases platelet aggregation)

19
New cards

What is the MOA for cilostazol?

inhibits platelet phosphodiesterase III (increases cAMP which decreases platelet aggregation)

20
New cards

What is the MOA for vorapaxar

inhibits thrombin and thrombin receptor agonist peptide (TRAP) at PAR-1 receptor

21
New cards

What is the onset and duration for dipyridamole?

Rapid onset (hours) and short duration (hours

22
New cards

What is the onset and duration for cilostazole?

Rapid onset (hours) and short duration (hours)

23
New cards

What is the onset and duration for vorapaxar?

Slow onset (days) and long duration (up to 1 month)

24
New cards

What are the SE for dipyridamole?

dizziness, HA, GI upset

25
New cards

What are the SE for cilostazol?

Dizziness, pedal edema, palpitations, HA, GI upset

26
New cards

What are the SE for vorapaxar?

bleeding, rash

27
New cards

Which anti-platelet therapies are the strongest? Weakest?

Best: GP2P3A blockers and cangrilor
Middle: Oral P2YA
Least: ASA, miscellaneous

28
New cards

List the glycoprotein IIb/IIIa receptor inhibitors

Eptifibatide (Integrilin)
Tirofiban (Aggrastat)

29
New cards

What is the MOA for eptifibatide and tirofiban?

block GP2B3A receptor (reversible)

30
New cards

What is the onset and duration for eptifibatide and tirofiban?

immediate onset, duration hours

31
New cards

What are the SE for eptifibatide and tirofiban?

Bleeding, thrombocytopenia (pseudo- and true)

32
New cards

What happens to clopidogrel in patients who are taking esomeprazole or omeprazole?

clopidogrel prodrug may remain inactive when taken with esomeprazole or omeprazole

33
New cards

What is the MOA of warfarin (Coumadin)?

VKA: Vitamin K epoxide reductase inhibitor (prolongs clotting time by inhibiting synthesis of vitamin K factors II, VII, IX, and X)

Inhibits Proteins C and S

34
New cards

What is the onset and duration of Warfarin?

delayed onset (days to kick in)

delayed duration (days to go away)

35
New cards

What is the metabolism of warfarin and risks

Hepatic —> NUMEROUS drug/diet interactions!!

36
New cards

What is the monitoring requirement of warfarin (Coumadin)?

CBC

INR: usually 2.0-3.0, consider reduced (1.8-2.2) for high bleed risk

37
New cards

What are the side effects of warfarin (Coumadin)?

bleeding, skin necrosis

38
New cards

Which medications increase INR with warfarin? Which decrease INR?

Increase: azole antifungals, most ABX, some anti-arrythmics
Decrease: rifampin, phenobarbital, primidone, carbamazepine, cholestyramine


**run drug interaction screen

39
New cards

What are the food interactions with warfarin (Coumadin)?

the leafier/greener the food, the more vitamin K
Decrease the anticoagulant effect of warfarin!

40
New cards

What is the reversal agents of warfarin?

Vitamin K (po, SC, IV, dietary)
Fresh frozen plasma (factors II, VII, IX, X)
Prothrombin complex concentrates (actived and inactivated factors)

41
New cards

List the direct thrombin (IIa) inhibitor

dabigatran (Pradaxa)

42
New cards

List the factor Xa inhibitors

rivaroxaban (Xarelto)
Apixaban (eliquis)
Edoxaban (savaysa)

43
New cards

What are the advantages of DOACs (direct oral anticoagulants)?

rapid onset/offset, fewer DI, minimal food interactions, more predicable dosing, decrease monitoring

44
New cards

What is the onset and duration of DOACs?

rapid (hours) onset, duration days

45
New cards

What is the monitoring for DOACs?

SCr

46
New cards

What are the side effects of DOACs?

bleeding, N/V

47
New cards

When should you use DOACs?

Patients with non-valvular AF, pulmonary embolism, deep vein thrombosis, secondary prevention of VTE, postop VTE prophylaxis

48
New cards

What are the reversal agents for DOACs?

49
New cards

How do you typically dose DOACs?

Once daily dosing: rivaroxaban, edoxaban, betrixaban
Twice daily dosing: dabigatran, apixaban

Dose reductions warranted for renal dysfunction

*more complex dosing for VTE (loading dose, etc)

50
New cards

When should you avoid use of edoxaban?

when CrCl > 95 mL/min (clears drug too fast)

51
New cards

When should you avoid use of DOACs?

Obesity, mechanical valves, malignancy, decreased renal function

52
New cards

What is the MOA for unfractionated heparin (UFH)?

Binds to antithrombin III, which then inhibits factors IIa, IXa, Xa, XIa, XIIa

Binds to numerous other proteins resulting in unpredictable response

*does not affect clot-bound thrombin or platelet-bound Xa

53
New cards

What is low molecular weight heparin?

Cleaved UFH to minimize protein interactions

54
New cards

List the LMWH/factor Xa inhibitors

Enoxaparin (Lovenox) - inhibits Xa and IIa
Fondaparinus (Arixtra) - inhibits Xa

55
New cards

what is the MOA for LMWH/Factor X inhibitors

Bind to antithrombin III to inhibit factor Xa ( and IIA for Lovenox)

56
New cards

What is the black box warning for LMWH?

57
New cards

What is the monitoring for parenteral anticoagulants?

CBC

58
New cards

What are the side effects for heparin, enoxaparin, and fondaparinux?

Bleeding, decreased platelets
Injection site bruising (enoxaparin, fondaparinux)

59
New cards

What is the MOA for direct thrombin inhibitors (DTI)?

Directly inhibits factor IIa (thrombin)

Bind free and clot associated thrombin

60
New cards

List the DTIs

Bivalirudin, (kidney clearance) argatroban (liver clearance)
*Hospital drugs; IV only

61
New cards

What is the monitoring for argatroban and bivalirudin?

CBC
PTT
LFTs (argatroban)
SCr (Bivalirudin)

62
New cards

What is the reversal agent for parenteral agents?

heparin and LMWH: protamine

fondaparinux, argatroban, bivalirudan: none

63
New cards

What is HIT?

Heparin induced thrombocytopenia
Type I: mild, transient thrombocytopenia
Type II: autoantibodies agains heparin-PF4 complex —> thrombosis

64
New cards

How do we diagnose HIT? (timing, platelets, labs, etc)

Onset 5-10 days after initiation
Platelet decrease >=50%
New thrombosis
+ PF4-heparin Ab
Probability score

65
New cards

How do you manage HIT?

STOP heparin products

Anticoagulate with DTI or fondaparinux (may transition to warfarin)

Treat at least 4 weeks OR 3 months if thrombosis
note heparin allergy

66
New cards

What is the MOA for fibrinolytics (alteplase, tenecteplase)?

Enhance plasminogen to plasmin reaction —> more fibrin breakdown

67
New cards

List the fibrinolytics

Alteplase (TPA)
Tenecteplase

68
New cards

What are the indications for alteplase (TPA) and tenecteplase?

Given in an ambulance or hospital ED


Acute ischemic stroke, STEMI, pulmonary embolus, peripheral arterial occlusion

69
New cards

What is the monitoring for alteplase and tenecteplase?

CBC, resolution of symptoms

70
New cards

What are the SE for alteplase (TPA) and tenecteplase?

bleeding
intracranial hemorrhage